We’re still figuring out the side effects of GLP-1 weight-loss drugs

MIT Technology Review ·
Technology

This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age. Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar…

Read original article on MIT Technology Review →

Related news